StonvexLoading…
StonvexStonvexStonvexCore line items from CMBMF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $159.65M | $177.29M | $136.97M | $92.30M |
Operating Income | $-27.96M | $-70.41M | $-58.97M | $-27.87M |
Net Income | $-38.54M | $-74.45M | $-67.22M | $-32.69M |
EPS (Diluted) | $-1.34 | $-2.65 | $-2.40 | $-1.17 |
Total Assets | $137.14M | $173.73M | $194.33M | $221.06M |
Total Liabilities | $173.09M | $176.97M | $192.46M | $187.00M |
Cash & Equivalents | $11.33M | $34.92M | $46.49M | $42.57M |
Free Cash Flow OCF − CapEx | $-16.15M | $-21.38M | $-10.56M | $-17.33M |
Shares Outstanding | 28.94M | 28.61M | 28.24M | 28.21M |